Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Echocardiographic Assessment of Pulmonary Artery Pressures
Clinical Trial ( IRB ) #: 22-144-1
Title: Echocardiographic Assessment of Pulmonary Artery Pressures
Principal Investigator: Dr. Agnes Kim
Description: Pulmonary hypertension (PHT) is a complex and challenging hemodynamic condition which is characterized by pathologic increase in mean Pulmonary Arterial Pressure (mPAP) >20 mm of Hg at rest.1 The elevated pulmonary pressures could be due to a variety of underlying causes such as lung disease, left heart disease or disease affecting small pulmonary vessels. The gold standard for a definitive diagnosis of PHT is a right heart catheterization (RHC), done invasively to assess filling pressures.2 Nevertheless, immense improvement in the technology over last few decades has made the noninvasive quantification of pulmonary pressures with increased sensitivity possible by transthoracic echocardiography (TTE).2 Echocardiography, is currently the first imaging modality in patients where PHT is suspected. It not only estimates the systolic pulmonary arterial pressures, but also provides useful information on right ventricle function, left ventricle systolic and diastolic function, as well as valvular disease that might be contributing the elevated pulmonary pressures.3 The goal is to assess the accuracy of mPAP calculated through echocardiographic assessment of PVAT and mPAP obtained through RHC.
  Hypertension/High Blood Pressure
Eligibility Criteria: Check with study contact
How to Contact: Sharon DiMauro. Telephone: (860) 679-2692. Email: dimauro@uchc.edu
Enrollment Status/Comments: Enrolling/recruiting. For current recruitment status, please check with study contact.